Pharmaceutical

Crinetics Pharmaceuticals gets grant for patent granted for somatostatin modulators for treating hormone-related conditions

Discover how Crinetics Pharmaceuticals Inc's patent for compounds modulating somatostatin activity can suppress hormone secretion in mammals. Explore the detailed framework for hormone modulation and SSTR2 activity regulation.

Mar 30, 2024 - 00:00
Discover how Crinetics Pharmaceuticals Inc's patent for compounds modulating somatostatin activity can suppress hormone secretion in mammals. Explore the detailed framework for hormone modulation and SSTR2 activity regulation.
Read the original article

Tags:

Previous Article

Gamida Cell gets grant for method of preparing transplantable NK cell fraction f...

Next Article

Yield10 Bioscience gets grant for genetically engineered oilseed plant expressin...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Amgen scores Otezla patent win in court to keep competition at bay

Amgen scores Otezla patent win in court to keep competi...

Apr 20, 2023

STAT+: Major pharma companies call on their suppliers to reduce carbon footprints

STAT+: Major pharma companies call on their suppliers t...

Jul 22, 2023

FDA greenlights new long-term treatment option for opioid use disorder

FDA greenlights new long-term treatment option for opio...

May 24, 2023